Advanced search
Publication Cover
Annals of Medicine Volume 42, 2010 - Issue 3
Submit an article Journal homepage
1,436
Views
32
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

Jian-Jun Li Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. ChinaCorrespondence[email protected]
,
Zong-Liang Lu Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
,
Wen-Rong Kou Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
,
Zuo Chen Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
,
Yang-Feng Wu Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
,
Xue-Hai Yu Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
,
Yu-Cheng Zhao Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, P. R. China
& on behalf of the Chinese Coronary Secondary Prevention Study (CCSPS) Group show all
Pages 231-240 | Received 26 Apr 2009, Accepted 21 Jan 2010, Published online: 30 Mar 2010

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Cesare R. Sirtori, Chiara Pavanello, Laura Calabresi & Massimiliano Ruscica. (2017) Nutraceutical approaches to metabolic syndrome. Annals of Medicine 49:8, pages 678-697.
Read now
Xingjiang Xiong, Pengqian Wang, Xiaoke Li, Yuqing Zhang & Shengjie Li. (2017) The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: A systematic review. Critical Reviews in Food Science and Nutrition 57:9, pages 1831-1851.
Read now
Miao Hu, G Neil Thomas & Brian Tomlinson. (2011) Lipid disorders in Chinese populations. Clinical Lipidology 6:5, pages 549-562.
Read now

Articles from other publishers (29)

Shreanshi Agrahari, Ankit Kumar Singh, Ida Tiwari & Saripella Srikrishna. (2024) Electrochemical deposition of Pd on MoS2 supported graphene nanoflakes over functionalised MWCNTs as an immunosensor for detection of lung cancer biomarker. Microchemical Journal 196, pages 109698.
Crossref
Jian-Jun Li, Shui-Ping Zhao, Dong Zhao, Guo-Ping Lu, Dao-Quan Peng, Jing Liu, Zhen-Yue Chen, Yuan-Lin Guo, Na-Qiong Wu, Sheng-Kai Yan, Zeng-Wu Wang & Run-Lin Gao. (2023) 2023 Chinese guideline for lipid management. Frontiers in Pharmacology 14.
Crossref
Arrigo F. G. Cicero, Federica Fogacci, Anca Pantea Stoian & Peter P. Toth. (2023) Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients 15:10, pages 2288.
Crossref
Shuai Wang, Yue Chen, Rui Wang, Bailing Ma, Zhenzhen Wang, Guanguang Tang, Siyu Wang, Yi He & Liping Qu. (2022) Effectiveness of red yeast rice on carotid atherosclerosis: A systematic review and meta-analysis. Frontiers in Pharmacology 13.
Crossref
Rong Yuan, Yahui Yuan, Lidan Wang, Qiqi Xin, Ya Wang, Weili Shi, Yu Miao, Sean Xiao Leng, Keji Chen & Weihong Cong. (2022) Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta−analysis. Frontiers in Pharmacology 13.
Crossref
Yuan Lu, Haibo Zhang, Jiapeng Lu, Qinglan Ding, Xinyue Li, Xiaochen Wang, Daqi Sun, Lingyi Tan, Lin Mu, Jiamin Liu, Fang Feng, Hao Yang, Hongyu Zhao, Wade L. Schulz, Harlan M. Krumholz, Xiangbin Pan, Jing Li, Chun Huang, Zhong Dong, Bo Jiang, Zhigang Guo, Yingyi Zhang, Jixin Sun, Yuhuan Liu, Zeping Ren, Yaqing Meng, Zhifen Wang, Yunfeng Xi, Liying Xing, Yuanmeng Tian, Jianwei Liu, Yao Fu, Ting Liu, Wei Sun, Shichun Yan, Lin Jin, Yang Zheng, Jing Wang, Jing Yan, Xiaoling Xu, Yeji Chen, Xiuya Xing, Luan Zhang, Wenling Zhong, Xin Fang, Liping Zhu, Yan Xu, Xiaolei Guo, Chunxiao Xu, Gang Zhou, Lei Fan, Minjie Qi, Shuzhen Zhu, Junfeng Qi, Junlin Li, Li Yin, Qiong Liu, Qingshan Geng, Yingqing Feng, Jiabin Wang, Hong Wen, Xuemei Han, Puyu Liu, Xianbin Ding, Jie Xu, Ying Deng, Jun He, Gui'e Liu, Chenxi Jiang, Shun Zha, Cangjiang Yang, Guoxia Bai, Yue Yu, Zongji Tashi, Lin Qiu, Zhiping Hu, Hupeng He, Jing Zhang, Minru Zhou, Xiaoping Li, Jianhua Zhao, Shaoning Ma, Yitong Ma, Ying Huang, Yuchen Zhang, Fanka Li & Jiacong Shen. (2021) Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China. JAMA Network Open 4:9, pages e2127573.
Crossref
Chunhui Zhao, Sen Li, Junhong Zhang, Yuanyun Huang, Luoqi Zhang, Feng Zhao, Xia Du, Jinli Hou, Tong Zhang, Chenjing Shi, Ping Wang, Ruili Huo, Owen L. Woodman, Cheng Xue Qin, Haiyu Xu & Luqi Huang. (2020) Current state and future perspective of cardiovascular medicines derived from natural products. Pharmacology & Therapeutics 216, pages 107698.
Crossref
Bunleu Sungthong, Chenchira Yoothaekool, Sornsalak Promphamorn & Wiraphol Phimarn. (2020) Efficacy of red yeast rice extract on myocardial infarction patients with borderline hypercholesterolemia: A meta-analysis of randomized controlled trials. Scientific Reports 10:1.
Crossref
Danyan Xu, Jiahui Hu, Qinghua Wu, Zhiming Du, Yusheng Xue, Xu Zhang, Yi Li, Yushan Chen, Xiaoping Chen, Hong Zhang & Shuiping Zhao. (2017) Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease. Oncotarget 9:10, pages 9489-9497.
Crossref
Jung Chao, Yuntao Dai, Robert Verpoorte, Wing Lam, Yung-Chi Cheng, Li-Heng Pao, Wei Zhang & Shilin Chen. (2017) Major achievements of evidence-based traditional Chinese medicine in treating major diseases. Biochemical Pharmacology 139, pages 94-104.
Crossref
Na-Qiong Wu, Yuan-Lin Guo, Ping Ye, Hong Chen, Yan-Fang Li, Qi Hua, Cheng-Gang Zhu, Ying Gao, Ping Qing, Xiao-Lin Li, Yao Wang, Geng Liu, Qian Dong & Jian-Jun Li. (2017) Statins usage and target achievement of LDL-C level in Chinese patients with coronary artery disease impacted by 2013 ACC/AHA cholesterol guideline. IJC Metabolic & Endocrine 14, pages 33-37.
Crossref
Kerry Layne & Albert Ferro. (2016) Traditional Chinese medicines in the management of cardiovascular diseases: a comprehensive systematic review. British Journal of Clinical Pharmacology 83:1, pages 20-32.
Crossref
Lingjun Li, Xiuwen Zhou, Na Li, Miao Sun, Juanxiu Lv & Zhice Xu. (2015) Herbal drugs against cardiovascular disease: traditional medicine and modern development. Drug Discovery Today 20:9, pages 1074-1086.
Crossref
Maaike C. Gerards, Ruben J. Terlou, Huixin Yu, C.H.W. Koks & V.E.A. Gerdes. (2015) Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis. Atherosclerosis 240:2, pages 415-423.
Crossref
Arrigo F.G. Cicero, Angelo Parini & Martina Rosticci. (2015) Nutraceuticals and cholesterol-lowering action. IJC Metabolic & Endocrine 6, pages 1-4.
Crossref
Xingjiang Xiong, Pengqian Wang, Xiaoke Li & Yuqing Zhang. (2015) Qigong for Hypertension. Medicine 94:1, pages e352.
Crossref
J. Le Bloc’h, T. Pauquai & C. Bourges. 2015. Foods, Nutrients and Food Ingredients with Authorised EU Health Claims: Volume 2. Foods, Nutrients and Food Ingredients with Authorised EU Health Claims: Volume 2 139 151 .
Wenping Tang, Xuntao Zhu & Zhaoyong Ba. 2014. Handbook of Food Chemistry. Handbook of Food Chemistry 1 20 .
Wenping Tang, Xuntao Zhu & Zhaoyong Ba. 2015. Handbook of Food Chemistry. Handbook of Food Chemistry 1035 1060 .
Yan Zhang, Jun Liu, Sha Li, Rui-Xia Xu, Jing Sun & Jian-Jun Li. (2014) Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats. Lipids in Health and Disease 13:1.
Crossref
Patrick M. Moriarty, Eli M. Roth, Adam Karns, Ping Ye, Shui-Ping Zhao, Yuhua Liao, David M. Capuzzi, Harold E. Bays, Fumin Zhang, Shaowen Liu, Alan J. Reichman, Osvaldo A. Brusco, Guoping Lu, Sam Lerman, Zhenwen Duan, Shuren Guo, Ping Lan Liu, Junxian Zhao, Yan Zhang & Simon Li. (2014) Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study. Journal of Clinical Lipidology 8:6, pages 568-575.
Crossref
Yuan-Lin Guo, Wei Zhang & Jian-Jun Li. (2014) PCSK9 and lipid lowering drugs. Clinica Chimica Acta 437, pages 66-71.
Crossref
Jie Wang & Xingjiang Xiong. (2013) Evidence-Based Chinese Medicine for Hypertension. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-12.
Crossref
Xingjiang Xiong, Xiaochen Yang, Wei Liu, Fuyong Chu, Pengqian Wang & Jie Wang. (2013) Trends in the Treatment of Hypertension from the Perspective of Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-13.
Crossref
Clinton W. Yang & Shaker A. Mousa. (2012) The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. Complementary Therapies in Medicine 20:6, pages 466-474.
Crossref
Xiaojie Xie, Yifan Wang, Songzhao Zhang, Guidi Zhang, Yinchuan Xu, Honghao Bi, Alan Daugherty & Jian-an Wang. (2012) Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis. The Journal of Nutritional Biochemistry 23:6, pages 549-556.
Crossref
Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Roberto Bolli, Zuo Chen, Yang-Feng Wu, Xue-Hai Yu & Yu-Cheng Zhao. (2012) Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS). International Journal of Cardiology 154:3, pages 362-365.
Crossref
Jian-Jun Li, Ping Yang, Jun Liu, Yan-Jun Jia, Zi-Cheng Li, Yuan-Lin Guo, Na-Qiong Wu, Yi-Da Tang & Li-Xin Jiang. (2012) Impact of 10mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers. Clinica Chimica Acta 413:1-2, pages 139-142.
Crossref
Yuan-Lin Guo, Jun Liu, Jian-Jun Li, Cheng-Gang Zhu, Ping Qing, Yan-Jun Jia, Na-Qiong Wu, Shao-Ping Nie, Zi-Cheng Li, He-Song Zeng & Ping Yang. (2011) A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery disease in real world cardiovascular practice. International Journal of Cardiology 153:2, pages 211-212.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.